Skip to main content
Curtis Chong, MD, Oncology, Palo Alto, CA

Curtis R Chong MD


Clinical Fellow in Medicine, Dana-Farber Cancer Institute

Join to View Full Profile
  • 300 Pasteur DrPalo Alto, CA 94304

  • Phone+1 650-723-4000

Dr. Chong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2008

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2010 - 2026
  • CA State Medical License
    CA State Medical License 2016 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2020
  • NJ State Medical License
    NJ State Medical License 2017 - 2019
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • A phase Ia/Ib, open label, multicenter, dose-escalation study of BI 907828 (MDM2-p53 antagonist) in adult patients with advanced or metastatic solid tumors. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • مضادات الفيروسات التي لم تكن يوما كذلك: نتائج مضللة كانت نِتاج إعادة توجيه أدوية مُرخصة لمعالجة الكوفيد 19
    مضادات الفيروسات التي لم تكن يوما كذلك: نتائج مضللة كانت نِتاج إعادة توجيه أدوية مُرخصة لمعالجة الكوفيد 19July 11th, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: